[Form 4] Celsius Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
John Fieldly, who is both Chief Executive Officer and a director of Celsius Holdings, Inc. (CELH), reported a sale of 143,167 shares of the company's common stock on 08/07/2025 at a reported price of $51.18 per share. After the reported transaction, the filing shows he directly beneficially owned 895,410 shares.
The Form 4 indicates the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2025. The form was filed by one reporting person and signed by an attorney-in-fact on 08/08/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: CEO sale of 143,167 CELH shares under an established 10b5-1 plan; direct holdings now 895,410 shares.
The filing documents a routine insider sale by John Fieldly executed on 08/07/2025 and reported on Form 4. The transaction is coded as a sale and shows a per-share price of $51.18 with direct beneficial ownership of 895,410 shares following the sale. Because the sale was conducted pursuant to a Rule 10b5-1 plan adopted 03/07/2025, this indicates a pre-arranged disposition rather than an ad hoc trade. For investors, the entry is a clear disclosure of insider liquidity activity but not, by itself, evidence of a change in corporate strategy or performance.
TL;DR: Use of a Rule 10b5-1 plan provides affirmative defense; filing appears complete and timely.
The Form 4 explicitly notes the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/07/2025, and the document is signed by an attorney-in-fact on 08/08/2025. That procedural detail is important for governance transparency because pre-established plans are designed to avoid perceptions of trading on nonpublic information. The report lists the reporting person as both CEO and director and indicates the form was filed by one reporting person, satisfying single-person reporting requirements.